TS
Todd Sone
Investor at Scipher Medicine
Israel
Overview
Todd Sone is a General Partner at aMoon Fund in Israel, with a strong track record of investing in and supporting companies in the healthcare and life sciences sectors. He has successfully invested in companies like Scipher Medicine and Mobilion Systems, contributing to their growth and success.
With a background in investing and serving on boards of various healthcare and biotech companies, Todd Sone has played a pivotal role in the development and advancement of innovative health technologies, making significant contributions to the industry.
Work Experience
General Partner
2021 - Current
Partnering with great HealthTech entrepreneurs.
Partner
2017 - 2021
Investor & Board Observer
2018
Bringing the $100 genome to market.
Investor & Board Director
2021
Using biomarkers to reduce trial & error and help physicians make informed treatment decisions.
Investor & Board Director
2020
The longer the track, the greater the separation of the field.
Investor & Board Director
2019
Treating migraine (better) without drugs and without looking like a Klingon.
Investor & Board Director
2019
Designing and developing antibodies using proprietary 3D modelling.
Investor & Board Director
2018
Finding that polyp (better).
Investor & Board Director
2018 - 2021
Clinical-stage precision oncology company with a lead asset in Ph 2 trials for desmoid tumor.
Partner
2009 - 2017
Growth capital to innovative healthcare companies.
Investor
2012 - 2017
Specialty pharma focused on injectable and infusion medications. Sold to Baxter.